Creative Biolabs expands plant EV platform for oral delivery research

Creative Biolabs said it has expanded research services for plant-derived extracellular vesicles, or plant EVs, to help scientists study natural nanovesicles for drug delivery, nutraceuticals and botanical therapeutics. The platform is aimed at improving isolation, characterization and functional testing of edible plant sources with potential oral delivery uses.

Why it matters: - Plant-derived extracellular vesicles are being explored as non-animal delivery systems with potential advantages in biocompatibility and stability. - The platform could help researchers study whether botanical nanovesicles can carry nucleic acids, proteins and other bioactive molecules through gastrointestinal conditions. - The work is aimed at applications in drug delivery, nutraceutical research, topical formulations, regenerative research and functional nutrition.

What happened: - Creative Biolabs announced a platform for plant-derived exosomes and related plant EV research. - The company expanded specialized services for isolation and characterization of plant EVs from edible botanical sources. - The platform covers medicinal plants, crops, fruits and root tissues. - The announcement was made from Shirley, New York, on July 27, 2026.

The details: - Creative Biolabs says the platform supports high-quality extraction, multi-omics profiling and functional evaluation. - The company highlighted complementary workflows that include ultracentrifugation, size-exclusion chromatography and affinity-based enrichment. - A senior scientist at Creative Biolabs said plant-derived vesicles contain naturally occurring lipids, nucleic acids and small bioactive molecules that may contribute to biological function. - The technical framework for fruit-derived vesicle research includes nanoparticle tracking analysis, transmission electron microscopy, molecular profiling and cellular uptake studies. - The company said fruit-derived sources such as citrus, grapes, apples and berries are drawing interest because of their abundance, accessibility and molecular composition. - Creative Biolabs said botanical nanovesicles may contain protective lipid structures that support delivery and preservation of associated bioactive components. - The company said its integrated workflows help evaluate particle integrity, cargo composition, biological interactions and cellular uptake properties. - The platform is positioned around edible plant-derived vesicles as candidates for oral delivery carriers.

Between the lines: - The announcement reflects broader interest in natural delivery platforms that avoid synthetic nanoparticles and viral systems. - The framing suggests Creative Biolabs is trying to standardize a research area that still depends on reproducible isolation and analysis methods. - The emphasis on food-derived vesicles signals a push to connect basic EV research with practical applications in oral dosing and functional products.

What's next: - Researchers can use the platform to test whether plant EVs are stable enough for gastrointestinal transit and effective enough for oral delivery. - Creative Biolabs is inviting researchers to explore its plant-derived extracellular vesicle isolation and functional evaluation services at more information. - The company is likely to keep building out characterization and functional testing tools as interest in botanical therapeutics grows.

The bottom line: - Creative Biolabs is betting that plant EVs can become a useful natural delivery platform if researchers can prove consistent isolation, cargo loading and biological performance.